Pfizer and Zhejiang Hisun to Invest $545 Million in Generic Drug JV
publication date: Feb 20, 2012
Pfizer and Zhejiang Hisun Pharma will put $545 million of assets into their branded generics JV. The investment will consist of off-patent drugs, manufacturing sites and cash. Hisun will contribute $295 million of these assets for a 51% stake in the JV, while Pfizer’s portion will be $250 million for the remaining 49%. The two companies signed a MOU to set up the JV in June 2011, and they have now made progress by approving a framework agreement and releasing the financial commitments of each party. More details....
Stock Symbols: (NYSE: PFE) (SHA: 600267)
Share this with colleagues:
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.